LERDELIMUMAB
UNII GX1FEU3QSM

Substance Identification & Data

This profile provides standardized clinical and technical data for Lerdelimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GX1FEU3QSM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 285985-06-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GX1FEU3QSM

CAS Registry Number

285985-06-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LERDELIMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C170107

National Cancer Institute reference terminology for clinical and research data.

INN ID

7882

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lerdelimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LERDELIMUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN TRANSFORMING GROWTH FACTOR .BETA.2) (HUMAN MONOCLONAL CAT-152 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CAT-152 .LAMDBA.-CHAIN, DIMER

LERDELIMUMAB [INN]

LERDELIMUMAB [WHO-DD]